In the ongoing battle against cancer, clinical trials remain a cornerstone for advancing new therapies, yet a staggering reality persists: only about 7.1% of U.S. adults diagnosed with cancer currently participate in these critical studies, hampering the pace of drug development. This alarmingly
Imagine a scenario where a patient with a suspected lung condition receives a diagnosis faster than ever before, thanks to technology that prioritizes critical cases and flags abnormalities with precision. This is the promise of artificial intelligence (AI) in NHS hospitals, a groundbreaking set of
I'm thrilled to sit down with Ivan Kairatov, a biopharma expert with a wealth of experience in technology and innovation within the industry. With a strong background in research and development, Ivan brings a unique perspective on how cutting-edge advancements, like wearable devices, are
As America's population continues to age at an unprecedented rate, with over 55 million individuals aged 65 and older, the demand for innovative aging care solutions has reached a critical juncture, posing unique challenges to healthcare systems, families, and communities grappling with gaps in
What if a fleeting video of a simple hand gesture could reveal a devastating neurological condition before any doctor suspects a problem, transforming the way we approach early diagnosis? Picture an ordinary smartphone clip, capturing subtle finger taps, silently holding the key to detecting
In a world where complex diseases like cancer and neurodegenerative disorders continue to challenge medical science, a transformative approach is emerging through artificial intelligence (AI). Imagine a tool so precise that it can predict the exact genetic targets needed to reverse a diseased
